$31.91
+5.99 (+23.11%)
CHYM News2 articles
Chime Shares Leap 21% on Strong Q2 and Raised Full-Year Guidance
Chime Financial (NASDAQ:CHYM) jumped 20.6% after Q2 revenue beat and raised full-year guidance, with revenue midpoint up $60M and EBITDA up $46.5M.
Esperion to Be Acquired by ARCHIMED in $1.1 Billion Deal, Shares Jump 56%
ARCHIMED will acquire Esperion Therapeutics for $3.16 per share in cash plus contingent value rights, valuing the deal at up to $1.1 billion. Esperion shares surged 56% on the news.